Rice Hall James & Associates’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-511,579
| Closed | -$1.12M | – | 270 |
|
|
2019
Q2 | $1.12M | Sell |
511,579
-187,728
| -27% | -$411K | 0.04% | 235 |
|
|
2019
Q1 | $4.19M | Buy |
699,307
+158,056
| +29% | +$947K | 0.13% | 133 |
|
|
2018
Q4 | $4M | Buy |
541,251
+151,254
| +39% | +$1.12M | 0.15% | 128 |
|
|
2018
Q3 | $5.66M | Sell |
389,997
-9,345
| -2% | -$136K | 0.2% | 114 |
|
|
2018
Q2 | $7.98M | Buy |
399,342
+187,545
| +89% | +$3.75M | 0.29% | 109 |
|
|
2018
Q1 | $3.71M | Buy |
211,797
+145,988
| +222% | +$2.56M | 0.14% | 119 |
|
|
2017
Q4 | $1.62M | Buy |
65,809
+24,325
| +59% | +$600K | 0.06% | 230 |
|
|
2017
Q3 | $1.07M | Sell |
41,484
-1,385
| -3% | -$35.8K | 0.05% | 234 |
|
|
2017
Q2 | $1.16M | Buy |
42,869
+8,042
| +23% | +$218K | 0.05% | 235 |
|
|
2017
Q1 | $1.04M | Buy |
34,827
+93
| +0.3% | +$2.77K | 0.05% | 246 |
|
|
2016
Q4 | $943K | Buy |
+34,734
| New | +$943K | 0.05% | 248 |
|